NFE2L2 and breast carcinoma: Furthermore, brusatol demonstrated significantly inhibitory effects against breast cancer MCF-7 cells with IC50 0.08 μM/L and improved the sensitivity of MCF-7 cells to Taxol via suppressing Nrf2 pathway and enhancing ROS levels of the breast cancer cells 87.